PCSK9 Inhibition for Therapeutic Decision-Making: Assessing the Value.

MedStar author(s):
Citation: Journal of the American College of Cardiology. 75(18):2309-2311, 2020 05 12.PMID: 32381161Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): EditorialSubject headings: *Acute Coronary Syndrome | *Proprotein Convertase 9 | Antibodies, Monoclonal, Humanized | Cost-Benefit Analysis | HumansYear: 2020Local holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007ISSN:
  • 0735-1097
Name of journal: Journal of the American College of CardiologyAll authors: Boden WE, Weintraub WSOriginally published: Journal of the American College of Cardiology. 75(18):2309-2311, 2020 May 12.Fiscal year: FY2020Digital Object Identifier: Date added to catalog: 2020-07-09
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32381161 Available 32381161

Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007

English

Powered by Koha